Published in Lancet on May 09, 2012
Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology (2013) 1.09
An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients. Medicine (Baltimore) (2015) 0.83
Rituximab for Sjögren syndrome-associated type II mixed cryoglobulinemic cerebral vasculitis. Neurol Neuroimmunol Neuroinflamm (2016) 0.81
Pseudoperipheral palsy: a case of subcortical infarction imitating peripheral neuropathy. BMC Neurol (2015) 0.80
Corkscrew angiopathy of intracranial vessels in a young stroke patient: a case report. J Med Case Rep (2012) 0.77
The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research. Psychiatr Clin North Am (2015) 0.76
Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control. Cell Death Dis (2016) 0.76
The Role of Catheter Angiography in the Diagnosis of Central Nervous System Vasculitis. Interv Neurol (2016) 0.75
IL-17 production by CSF lymphocytes as a biomarker for cerebral vasculitis. Neurol Neuroimmunol Neuroinflamm (2016) 0.75
Primary CNS vasculitis presenting as intraventricular bleeding. Ann Indian Acad Neurol (2016) 0.75
Primary Central Nervous System Vasculitis Mimicking a Cortical Brain Tumor: A Case Report. Brain Tumor Res Treat (2017) 0.75
Paraneoplastic Progressive Vasculopathy as the Presenting Manifestation of Polyneuropathy, Organomegaly, Endocrinopathy or Edema, M-Spike, and Skin Manifestations: A Case Report. J Stroke Cerebrovasc Dis (2016) 0.75
Diagnostic Value of Positron Emission Tomography Combined with Computed Tomography for Evaluating Critically Ill Neurological Patients. Front Neurol (2017) 0.75
An illustrative case of primary angiitis of the central nervous system. SAGE Open Med Case Rep (2014) 0.75
Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases. Clin Med Insights Arthritis Musculoskelet Disord (2016) 0.75
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience. Medicine (Baltimore) (2016) 0.75
Cerebral vasculitis and intracranial multiple aneurysms in a child with Lyme neuroborreliosis. JMM Case Rep (2017) 0.75
[Primary central nervous system vasculitis]. Z Rheumatol (2015) 0.75
Idiopathic hypereosinophilic syndrome: a new cause of vasculitis of the central nervous system. J Neurol (2015) 0.75
Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis. Clin Rheumatol (2014) 0.75
Central nervous system angiitis in Hodgkin's disease. J Neurol (2013) 0.75
Challenges of stroke management in resource-limited settings: A case-based reflection. Malawi Med J (2017) 0.75
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30
Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med (2002) 7.05
Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68
Cheminformatics analysis and learning in a data pipelining environment. Mol Divers (2006) 3.86
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum (2006) 3.64
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc (2004) 3.45
Polymyalgia rheumatica and giant-cell arteritis. Lancet (2008) 3.40
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol (2007) 2.99
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum (2003) 2.64
Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum (2003) 2.62
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J (2005) 2.45
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum (2004) 2.32
Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum (2011) 2.31
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med (2007) 2.27
Intracranial saccular aneurysm enlargement determined using serial magnetic resonance angiography. J Neurosurg (2002) 2.09
Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 2.08
Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke (2011) 2.07
Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up. J Biomol Screen (2005) 2.05
The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC Neurol (2003) 1.98
Age-related differences in unruptured intracranial aneurysms: 1-year outcomes. J Neurosurg (2014) 1.96
Central nervous system manifestations of cardiac myxoma. Arch Neurol (2007) 1.94
Incidence and outcome of cervical artery dissection: a population-based study. Neurology (2006) 1.92
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol (2002) 1.91
Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89
Premature menopause or early menopause and risk of ischemic stroke. Menopause (2012) 1.84
The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet (2002) 1.82
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80
Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology (2005) 1.77
Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum (2007) 1.76
Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int (2004) 1.71
The natural history of lone atrial flutter. Ann Intern Med (2004) 1.68
Mirror aneurysms: a reflection on natural history. J Neurosurg (2012) 1.67
Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg (2012) 1.60
Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke (2003) 1.52
Coils or clips in subarachnoid haemorrhage? Lancet (2002) 1.46
Siblings with ischemic stroke study: results of a genome-wide scan for stroke loci. Stroke (2011) 1.45
Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience. JACC Cardiovasc Interv (2009) 1.45
The Familial Intracranial Aneurysm (FIA) study protocol. BMC Med Genet (2005) 1.45
A community-based study of stroke incidence after myocardial infarction. Ann Intern Med (2005) 1.44
Are distal protection devices 'protective' during carotid angioplasty and stenting? Stroke (2011) 1.41
Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis (2009) 1.40
Cause-specific mortality after first cerebral infarction: a population-based study. Stroke (2003) 1.39
The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med (2006) 1.38
Population-based study of symptomatic internal carotid artery occlusion: incidence and long-term follow-up. Stroke (2004) 1.37
Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol (2005) 1.36
Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg (2006) 1.28
The natural history of radiographically defined vertebrobasilar nonsaccular intracranial aneurysms. Cerebrovasc Dis (2005) 1.26
Recovery after spinal cord infarcts: long-term outcome in 115 patients. Neurology (2011) 1.25
Guglielmi detachable coil treatment of ruptured saccular cerebral aneurysms: retrospective review of a 10-year single-center experience. AJNR Am J Neuroradiol (2003) 1.24
The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail (2007) 1.23
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis (2012) 1.23
Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care (2009) 1.20
Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc (2004) 1.19
Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum (2003) 1.19
Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke (2009) 1.18
Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol (2012) 1.18
Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol (2005) 1.18
Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol (2009) 1.17
Small (< 10-mm) incidentally found intracranial aneurysms, Part 1: reasons for detection, demographics, location, and risk factors in 212 consecutive patients. Neurosurg Focus (2011) 1.16
Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review. J Stroke Cerebrovasc Dis (2007) 1.14
Postcardiac surgical cognitive impairment in the aged using diffusion-weighted magnetic resonance imaging. Ann Thorac Surg (2007) 1.14
Polymyalgia rheumatica. Best Pract Res Clin Rheumatol (2004) 1.11
Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis (2007) 1.10
Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology (2013) 1.09
Ischemic stroke after heart failure: a community-based study. Am Heart J (2006) 1.07
Primary central nervous system vasculitis presenting with intracranial hemorrhage. Arthritis Rheum (2011) 1.07
Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis Rheum (2005) 1.06
Small (< 10-mm) incidentally found intracranial aneurysms, Part 2: treatment recommendations, natural history, complications, and short-term outcome in 212 consecutive patients. Neurosurg Focus (2011) 1.06
Validation and refinement of the ABCD2 score: a population-based analysis. Stroke (2009) 1.04
Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke (2008) 1.04
Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 1.04
Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc (2003) 1.03
Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) (2004) 1.02
Improved image quality of intracranial aneurysms: 3.0-T versus 1.5-T time-of-flight MR angiography. AJNR Am J Neuroradiol (2004) 1.02
Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk. Stroke (2012) 1.02
Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum (2008) 1.01
The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intracranial aneurysm. Stroke (2010) 1.01
Unruptured aneurysms. J Neurosurg (2002) 1.01
Evaluation of transient ischemic attack in an emergency department observation unit. Neurocrit Care (2008) 1.01
Impact of restricting enrollment in stroke genetics research to adults able to provide informed consent. Stroke (2008) 1.00
Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group. Stroke (2014) 0.99
Direct medical costs of polymyalgia rheumatica. Arthritis Rheum (2005) 0.99
Common mitochondrial sequence variants in ischemic stroke. Ann Neurol (2010) 0.97
Candidate gene polymorphisms for ischemic stroke. Stroke (2009) 0.96
Prospective risk of hemorrhage in patients with vertebrobasilar nonsaccular intracranial aneurysm. J Neurosurg (2004) 0.95
Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. J Stroke Cerebrovasc Dis (2012) 0.95
Treatment of carotid artery stenosis: medical therapy, surgery, or stenting? Mayo Clin Proc (2009) 0.94
Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken) (2010) 0.94
3.0-Tesla MR angiography of intracranial aneurysms: comparison of time-of-flight and contrast-enhanced techniques. J Magn Reson Imaging (2005) 0.93